Indication
Organ Transplant
5 clinical trials
5 products
Clinical trial
Evaluation of the Safety and Performance of Perla® Preservation Solution for Donor Liver and Kidney for TransplantationStatus: Completed, Estimated PCD: 2022-04-30
Clinical trial
Viral Specific T-cells (VSTs) for Treatment of Viral Infections After Solid Organ TransplantStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Product
Viral Specific T-cellsClinical trial
A Phase I Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant RecipientsStatus: Terminated, Estimated PCD: 2022-07-11
Product
CMV specific T-cellsClinical trial
Pharmacokinetics and Pharmacodynamic Study of Ruxolitinib for the Management of Acute and Chronic Graft Versus Host DiseaseStatus: Completed, Estimated PCD: 2023-05-13
Product
RuxolitinibClinical trial
Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant RecipientsStatus: Recruiting, Estimated PCD: 2025-09-11